Doç. Dr. Fehmi Hindilerden

Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study

Journal of Thrombosis and Thrombolysis, 2026

DOI 10.1007/s11239-026-03363-8 PMID 42565930 Texte intégral en libre accèsSource : OpenAlex

Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients

TURKISH JOURNAL OF MEDICAL SCIENCES, 2026

DOI 10.55730/1300-0144.6184 PMID 42058976 Texte intégral en libre accèsSource : OpenAlex

Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study

Journal of clinical medicine, 2026

DOI 10.3390/jcm15020854 PMID 41598791 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

(PB2953) REAL-WORLD EFFICACY AND CARDIOVASCULAR SAFETY OF ACALABRUTINIB IN B-CELL MALIGNANCIES: A TURKISH MULTICENTER EXPERIENCE COMPARING FRONTLINE INITIATION VS. TRANSITION AFTER IBRUTINIB INTOLERANCE Topic: 06. Chronic lymphocytic leukemia and related disorders -Clinical

2026

DOI 10.13140/rg.2.2.20277.44000 Source : OpenAlex

Evaluation of bloodstream infections in febrile neutropenic patients with hematological malignancy: a retrospective cohort study

BMC Infectious Diseases, 2026

DOI 10.1186/s12879-026-13465-6 PMID 42056949 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

CLINICAL IMPACT OF ELTROMBOPAG-ASSOCIATED IRON CHELATION IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER REAL-WORLD STUDY

Mediterranean Journal of Hematology and Infectious Diseases, 2026

DOI 10.4084/mjhid.2026.027 PMID 41821563 Texte intégral en libre accèsSource : ORCID

Real-World Outcomes of Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia

Hemato, 2026

DOI 10.3390/hemato7020016 Texte intégral en libre accèsSource : ORCID

A practical tool for predicting outcomes in essential thrombocythemia: Triple A risk model and beyond

Blood advances, 2026

DOI 10.1182/bloodadvances.2025017896 PMID 41092481 2 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

Emerging Survival Predictor Model in Essential Thrombocythemia: The AAA + Model

American Journal of Hematology, 2026

DOI 10.1002/ajh.70254 PMID 41793248 Texte intégral en libre accèsSource : OpenAlex

MİYELOPROLİFERATİF NEOPLAZMLARDA SPLANKNİK VEN TROMBOZUNUN DEĞERLENDİRİLMESİ: THD KRONİK MİYELOSİTER LÖSEMİ VE KRONİK MİYELOPROLİFERATİF NEOPLAZMLAR VE HEMOSTAZ - TROMBOZ BİLİMSEL ALT KOMİTELERİ ÇOK MERKEZ ÇALIŞMASI

Bursa Uludag University - AVESIS, 2025

Source : OpenAlex

MİYELOPROLİFERATİF NEOPLAZMLARDA SPLANKNİK VEN TROMBOZUNUN DEĞERLENDİRİLMESİ: THD KRONİK MİYELOSİTER LÖSEMİ VE KRONİK MİYELOPROLİFERATİF NEOPLAZMLAR VE HEMOSTAZ - TROMBOZ BİLİMSEL ALT KOMİTELERİ ÇOK MERKEZ ÇALIŞMASI

Kocaeli Üniversitesi - AVESİS, 2025

Source : OpenAlex

Extranodal Nasal-Type NK/T-Cell Lymphoma Treatment: Analysis from a Multicenter Study

Nigerian Journal of Clinical Practice, 2025

DOI 10.4103/njcp.njcp_499_24 PMID 40462333 Texte intégral en libre accèsSource : OpenAlex

The role of CD40L-expressing CXCR5+CD8+ follicular cytotoxic T cells in chronic lymphocytic leukemia

Immunologic Research, 2025

DOI 10.1007/s12026-025-09672-z PMID 40768060 1 citation (Europe PMC) Source : ORCID

Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology

Journal of Thrombosis and Thrombolysis, 2025

DOI 10.1007/s11239-024-03043-5 PMID 39527392 5 citations (Europe PMC) Source : ORCID

ABCL-288: Cisplatin-Induced Cardiomyopathy After Salvage Chemotherapy for Non-Hodgkin Lymphoma

Clinical Lymphoma Myeloma & Leukemia, 2025

DOI 10.1016/s2152-2650(25)02243-8 1 citation (OpenAlex) Source : OpenAlex

A practical tool for predicting outcomes in essential thrombocythemia: Triple (or quadruple) a risk model

Blood, 2025

DOI 10.1182/blood-2025-3805 Source : OpenAlex

SECONDARY SOLID CANCER FREQUENCY AND RISK FACTORS IN PHILADELPHIA- NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS

Hematology Transfusion and Cell Therapy, 2024

DOI 10.1016/j.htct.2024.04.005 Texte intégral en libre accèsSource : OpenAlex

Secondary Solid Cancers Among Patients with Philadelphia Chromosome- Negative Myeloproliferative Neoplasms: A Multicenter Study

Turkish Journal of Hematology, 2024

DOI 10.4274/tjh.galenos.2024.2024.0199 PMID 39113479 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

MPN-176 Clinical Significance of CALR Mutation in Patients With Essential Thrombocythemia

Clinical Lymphoma Myeloma & Leukemia, 2024

DOI 10.1016/s2152-2650(24)01410-1 Source : OpenAlex

Clinical Significance of CALR Mutation in Patients With Essential Thrombocythemia

Clinical Lymphoma Myeloma & Leukemia, 2024

DOI 10.1016/s2152-2650(24)00711-0 Source : OpenAlex

Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey

Blood, 2024

DOI 10.1182/blood-2024-193433 Texte intégral en libre accèsSource : OpenAlex

Poisoning by butylated hydroxytoluene quinone methide acting as a superwarfarin: first reported case in humans

Blood Coagulation & Fibrinolysis, 2024

DOI 10.1097/mbc.0000000000001307 PMID 38973518 1 citation (Europe PMC) Source : ORCID

Alectinib-induced Non-immune Hemolytic Anemia due to Erythrocyte Membrane Alterations: A Retrospective Evaluation

Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2024

DOI 10.4274/bmj.galenos.2024.2024.3-9 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

The Role of CD8+CXCR5+ Follicular Cytotoxic T Cell and Their Subsets in B Cell Responses and Diseases

Istanbul University Press eBooks, 2024

DOI 10.26650/b/ls17ls30.2025.007 Source : OpenAlex

International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report

Transfusion and Apheresis Science, 2023

DOI 10.1016/j.transci.2023.103662 PMID 36842884 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms

Turkish Journal of Hematology, 2023

DOI 10.4274/tjh.galenos.2023.2023.0169 PMID 37584526 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Raman spectroscopy-based biomarker screening by studying the fingerprint and lipid characteristics of Polycythem..a Vera cases blood serum

Photodiagnosis and Photodynamic Therapy, 2023

DOI 10.1016/j.pdpdt.2023.103572 PMID 37060986 5 citations (Europe PMC) Source : OpenAlex

Comparison of different plerixafor-based strategies for adequate hematopoietic stem cell collection in poor mobilizers

The European Research Journal, 2023

DOI 10.18621/eurj.1231251 Texte intégral en libre accèsSource : OpenAlex

POSTER: CT-236 Scabies Induced Hypereosinophilic Syndrome After Allogeneic Stem Cell Transplant: Case Report

Clinical Lymphoma Myeloma & Leukemia, 2023

DOI 10.1016/s2152-2650(23)00920-5 Source : OpenAlex

CT-236 Scabies Induced Hypereosinophilic Syndrome After Allogeneic Stem Cell Transplant: Case Report

Clinical Lymphoma Myeloma & Leukemia, 2023

DOI 10.1016/s2152-2650(23)01503-3 Texte intégral en libre accèsSource : OpenAlex

RETROSPECTIVE EVALUATION OF BONE MARROW FINDINGS IN AUTOIMMUNE HEMOLYTIC ANEMIAS

Hematology Transfusion and Cell Therapy, 2023

DOI 10.1016/j.htct.2023.09.068 Texte intégral en libre accèsSource : OpenAlex

Systemic Immune-Inflammation Index and Hodgkin Lymphoma: an Underexplored Relationship

Acta Oncologica Turcica, 2023

DOI 10.5505/aot.2023.62582 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores

Turkish journal of haematology : official journal of Turkish Society of Haematology, 2023

DOI 10.4274/tjh.galenos.2023.2023.0295 PMID 37791641 3 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

ABCL-116 R-Venetoclax Treatment in a B-Cell Prolymphocytic Leukemia Patient: A Challenging Case

Clinical Lymphoma Myeloma & Leukemia, 2023

DOI 10.1016/s2152-2650(23)01291-0 1 citation (OpenAlex) Source : OpenAlex

POSTER: ABCL-116 R-Venetoclax Treatment in a B-Cell Prolymphocytic Leukemia Patient: A Challenging Case

Clinical Lymphoma Myeloma & Leukemia, 2023

DOI 10.1016/s2152-2650(23)00741-3 Texte intégral en libre accèsSource : OpenAlex

The association of CMV infection with bacterial and fungal infections in hematopoietic stem cell transplant recipients: a retrospective single-center study.

PubMed, 2022

PMID 35403846 4 citations (Europe PMC) Source : OpenAlex

Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen

Hematology Reports, 2022

DOI 10.3390/hematolrep14030030 PMID 35893154 Texte intégral en libre accèsSource : OpenAlex

The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL

Clinical Lymphoma, Myeloma and Leukemia, 2022

DOI 10.1016/j.clml.2021.09.010 PMID 34629286 5 citations (Europe PMC) Source : ORCID

Increased Perforin- and IL-21-Expressing NK Cells in Patients with Early-Stage Chronic Lymphocytic Leukemia

Experimed, 2022

DOI 10.26650/experimed.1191622 2 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID

RITUXIMAB INDUCED LUNG DISEASE IN A MANTLE CELL LYMPHOMA PATIENT RECEIVING MAINTENANCE: CASE PRESENTATION

Hematology, Transfusion and Cell Therapy, 2022

DOI 10.1016/j.htct.2022.09.1245 Texte intégral en libre accèsSource : ORCID

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

Turkish Journal of Hematology, 2021

DOI 10.4274/tjh.galenos.2021.2021.0287 PMID 34521187 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Pralatrexate experience in PTCL: A multicenter retrospective study from Turkey.

PubMed, 2021

PMID 34565016 Texte intégral en libre accèsSource : OpenAlex

Pralatrexate experience in peripheral T-cell lymphoma: A multicenter retrospective study from Turkey

AYBU AVESIS, 2021

Source : OpenAlex

The impact of JAK2V617F mutation on Philadelphia-negative myeloproliferative neoplasms

TURKISH JOURNAL OF MEDICAL SCIENCES, 2021

DOI 10.3906/sag-2103-247 PMID 34482679 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients

Journal of Chemotherapy, 2021

DOI 10.1080/1120009x.2021.1976912 PMID 34514960 8 citations (Europe PMC) Source : OpenAlex

Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin’s Lymphoma

Frontiers in Oncology, 2021

DOI 10.3389/fonc.2021.601709 PMID 33816231 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study

International Journal of Clinical Oncology, 2021

DOI 10.1007/s10147-021-01863-6 PMID 33486624 47 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

IgG4 producing POEMS syndrome: A rarely recognized subtype.

Indian journal of pathology & microbiology, 2021

DOI 10.4103/ijpm.ijpm_995_20 PMID 34341279 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

An Experience on Pomalidomide in Patients within Relapsed/Refractory Multiple Myeloma - A Multicenter Study in Turkey

Journal of Pharmaceutical Research International, 2021

DOI 10.9734/jpri/2020/v32i4131047 Texte intégral en libre accèsSource : ORCID

MPN-376: The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms

Clinical Lymphoma Myeloma & Leukemia, 2020

DOI 10.1016/s2152-2650(20)31007-7 Source : OpenAlex